MYND Life Sciences's market cap is currently $1.68M. The company's EPS TTM is $-0.008; its P/E ratio is ―; MYND Life Sciences is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -332.99K	C$ -59.83K	C$ -86.12K	C$ 0.00	C$ 0.00
Operating Income	C$ -1.81M	C$ -3.06M	C$ -4.29M	C$ -56.47K	C$ -2.54K
EBITDA	C$ -1.83M	C$ -2.97M	C$ -4.31M	C$ 0.00	C$ 0.00
Net Income	C$ -1.52M	C$ -3.57M	C$ -4.37M	C$ -56.47K	C$ -2.54K
Balance Sheet
Cash & Short-Term Investments	C$ 257.00	C$ 412.00	C$ 1.90M	C$ 0.00	C$ 0.00
Total Assets	C$ 797.54K	C$ 654.12K	C$ 2.67M	C$ 70.00	C$ 0.00
Total Debt	C$ 3.00M	C$ 2.59M	C$ 2.32M	C$ 0.00	C$ 0.00
Net Debt	C$ 3.00M	C$ 2.59M	C$ 423.36K	C$ 0.00	C$ 0.00
Total Liabilities	C$ 5.77M	C$ 4.19M	C$ 2.74M	C$ 53.69K	C$ 1.83K
Stockholders' Equity	C$ -4.98M	C$ -3.53M	C$ -67.97K	C$ -53.62K	C$ -1.83K
Cash Flow
Free Cash Flow	C$ -198.26K	C$ -1.82M	C$ -3.13M	C$ -2.78K	C$ -708.00
Operating Cash Flow	C$ -198.26K	C$ -1.82M	C$ -2.98M	C$ -2.78K	C$ -708.00
Investing Cash Flow	C$ 198.10K	C$ -80.00K	C$ 2.13M	C$ 0.00	C$ 0.00
Financing Cash Flow	C$ 0.00	C$ 0.00	C$ 2.75M	C$ 2.78K	C$ 708.00

Currency in CAD

MYND Life Sciences Earnings and Revenue History

Income Statement >

MYND Life Sciences Debt to Assets

Balance Sheet >

MYND Life Sciences Cash Flow

Cash Flow >

MYND Life Sciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing